Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
03/2000
03/09/2000WO2000012049A2 A method for the treatment of staphylococcal disease
03/09/2000WO1999061590A9 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src
03/09/2000WO1999060017A3 Human tumour-derived polypeptide hormone phosphatonin
03/09/2000WO1999060013A3 Il-6 antagonist peptides
03/09/2000CA2633074A1 Elongase genes and uses thereof
03/09/2000CA2342251A1 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
03/09/2000CA2342250A1 Quinazoline derivatives as medicaments
03/09/2000CA2342222A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
03/09/2000CA2342205A1 Primate embryonic stem cells with compatible histocompatibility genes
03/09/2000CA2341699A1 A method for the treatment of staphylococcal disease
03/09/2000CA2341459A1 Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
03/09/2000CA2341308A1 Human latent transforming growth factor-.beta. binding protein 3
03/09/2000CA2339664A1 Thieno{2,3,-d}pyrimidinedione derivatives and their use as immunosuppressants
03/09/2000CA2249657A1 Novel compounds
03/08/2000EP0984012A2 Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties
03/08/2000EP0983766A1 A pharmaceutical composition for the treatment of rheumatoid disorders comprising sulphur, mustard seeds and a copper salt
03/08/2000EP0983294A1 B-ring estratriene diol sulphates
03/08/2000EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
03/08/2000EP0983260A2 3(5)-HETEROARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
03/08/2000EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds
03/08/2000EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
03/08/2000EP0983256A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
03/08/2000EP0983249A1 Processes and intermediates for preparing substituted indazole derivatives
03/08/2000EP0983229A1 Metalloproteinase inhibitors
03/08/2000EP0983228A1 Protease inhibitors
03/08/2000EP0983078A1 SIALOADHESIN FAMILY 4 cDNA
03/08/2000EP0983064A1 PYRROLES AS sPLA2 INHIBITORS
03/08/2000CN1246857A Substituted pyrimidinone and pyridinone compounds and their use
03/08/2000CN1246856A Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
03/08/2000CN1246801A Arginine silicate inositol complex and use thereof
03/08/2000CN1246362A Medicine for treating hyperosteogeny
03/08/2000CN1246360A Preparation used for orthopedics and its preparing process
03/08/2000CN1246351A Exterior-applied medicine for treating rheumatism and rheumatoid disease and its preparing process
03/08/2000CN1050126C Tri-substituted imidazoles compound, process for preparing it and use and pharmaceutical compositions containing them
03/07/2000US6034136 Certain cyclic thio substituted acylaminoacid amide derivatives
03/07/2000US6034122 Combined use of diclofenac and tribenoside to treat osteoarthritis
03/07/2000US6034107 5-Substituted picolinic acid compounds and their production process
03/07/2000US6034077 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/07/2000US6034061 Forming chondrocyte tissue in animal; administering bone morphogenic protein
03/07/2000US6033910 Antisense inhibition of MAP kinase kinase 6 expression
03/02/2000WO2000011171A2 Human rna-associated proteins
03/02/2000WO2000011170A1 14400 receptor, a g-protein coupled receptor
03/02/2000WO2000011163A1 Dcr5, a bmp-binding protein, and applications thereof
03/02/2000WO2000010993A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/02/2000WO2000010982A1 Quinazoline derivatives and pharmaceutical applications therof
03/02/2000WO2000010968A2 Novel aryl sulphonamide amino acid esters and analogues
03/02/2000WO2000010967A1 Novel aryl sulphonamides and analogues
03/02/2000WO2000010958A1 Vitamin d3 mimics
03/02/2000WO2000010604A1 Gene therapy for regulating smooth muscle cell tone
03/02/2000WO2000010596A1 Method of increasing bone toughness and stiffness and reducing fractures
03/02/2000WO2000010583A1 Human histone deacetylase gene hd4
03/02/2000WO2000010563A1 Novel substituted triazole compounds
03/02/2000WO2000010548A2 19-nor-vitamin d3 compounds with calcemic activity
03/02/2000WO2000010536A1 Extended release buccal bioadhesive tablet
03/02/2000WO1999058642A3 Secreted proteins and polynucleotides encoding them
03/02/2000WO1999058555A3 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues
03/02/2000WO1999045031A3 Cd147 binding molecules as therapeutics
03/02/2000WO1999011605A8 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
03/02/2000WO1998051662A3 Compounds and methods for the inhibition of the expression of vcam-1
03/02/2000CA2341370A1 Novel substituted triazole compounds
03/02/2000CA2341357A1 Quinazoline derivatives and pharmaceutical applications therof
03/02/2000CA2341028A1 Novel aryl sulphonamide amino acid esters and analogues
03/02/2000CA2340928A1 Novel arylsulphonamides and analogues
03/02/2000CA2340457A1 14400 receptor, a g-protein coupled receptor
03/02/2000CA2340277A1 Human rna-associated proteins
03/02/2000CA2339968A1 Dcr5, a bmp-binding protein, and applications thereof
03/02/2000CA2339800A1 Gene therapy for regulating smooth muscle cell tone
03/02/2000CA2339775A1 Vitamin d3 mimics
03/01/2000EP0982300A2 Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
03/01/2000EP0981545A1 Treatment of osteoporosis
03/01/2000EP0981523A1 CYCLIC ETHER VITAMIN D3 COMPOUNDS, 1$g(a) (OH) 3-EPI-VITAMIN D3 COMPOUNDS AND USES THEREOF
03/01/2000EP0981521A2 Novel macrocyclic compounds as metalloprotease inhibitors
03/01/2000EP0981514A1 3-epi vitamin d2 compounds and uses thereof
03/01/2000EP0981376A1 Targeted therapeutic delivery of vitamin d compounds
03/01/2000EP0981343A2 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
03/01/2000EP0981337A2 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones
03/01/2000EP0513387B1 Thiazole derivatives as active oxygen inhibitors
03/01/2000CN1246125A Peptides comprising a T-cell epitope specific to collagen II
03/01/2000CN1246119A Pyrrolo [3,4-d] pyrimidinone derivatives and their use as medicaments
03/01/2000CN1245714A Medicine for curing hyperosteogeny
03/01/2000CN1245711A Channel-freeing network-quickening strong bone-joining powder
03/01/2000CN1245704A Chinese pill for curing hyperosteogeny
02/2000
02/29/2000US6030964 Binds to retinoic acid receptors and useful for treating psoriasis, autoimmune diseases, tumors, rheumatoid arthritis and for inducing immunosuppression in organ transplantation
02/29/2000CA2281050A1 Nitric oxide releasing oxindole prodrugs for analgesic, anti-inflammatory and disease-modifying use
02/29/2000CA2280049A1 Diarylsulfonylurea binding proteins
02/24/2000WO2000009551A1 Human chordin-related proteins and polynucleotides encoding them
02/24/2000WO2000009537A2 Compounds having growth hormone releasing activity
02/24/2000WO2000009512A2 Bipyridine manganese complexes
02/24/2000WO2000009504A1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors
02/24/2000WO2000009503A1 Integrin receptor antagonists
02/24/2000WO2000009492A1 Tace inhibitors
02/24/2000WO2000009491A1 Calcilytic compounds
02/24/2000WO2000009485A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors
02/24/2000WO2000009143A1 Multivalent avb3 and metastasis-associated receptor ligands
02/24/2000WO2000009132A1 Calcilytic compounds
02/24/2000WO2000009130A2 New pharmaceutical uses for nos inhibitors
02/24/2000WO2000009129A1 C3a receptor ligands
02/24/2000WO2000009096A1 Injectable formulations of nanoparticulate naproxen
02/24/2000WO2000002905A3 Methods for accelerating bone and cartilage growth and repair
02/24/2000WO1999064565A3 Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells
1 ... 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 ... 820